Chipping away at the lung cancer genome
William J. Pao, Katherine E. Hutchinson · Nature Medicine · 2012
Cited by 192 works. doi:10.1038/nm.2697
Authors
References
- Global cancer statistics
- EGF receptor gene mutations are common in lung cancers from “never smokers” and are associated with sensitivity of tumors to gefitinib and erlotinib
- Anaplastic Lymphoma Kinase Inhibition in Non–Small-Cell Lung Cancer
- ROS1 Rearrangements Define a Unique Molecular Class of Lung Cancers
- RET, ROS1 and ALK fusions in lung cancer
- Activation of a novel human transforming gene, ret, by DNA rearrangement
- Identification of new ALK and RET gene fusions from colorectal and lung cancer biopsies
- New driver mutations in non-small-cell lung cancer
- KIF5B-RET fusions in lung adenocarcinoma
- New driver mutations in non-small-cell lung cancer